ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings
ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 独立董事关于第四届董事会第三十三次会议相关事项的独立意见 | 2021-04-27 | Chinese | |
| 股东大会议事规则（2021年4月） | 2021-04-27 | Chinese | |
| 对外担保管理制度（2021年4月） | 2021-04-27 | Chinese | |
| 独立董事2020年度述职报告（陈菡） | 2021-04-27 | Chinese | |
| 关于开展外汇套期保值业务可行性分析报告 | 2021-04-27 | Chinese | |
| 关于开展商品期货套期保值业务可行性分析报告 | 2021-04-27 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2021
15 filings
| |||||
| 36035136 | 独立董事关于第四届董事会第三十三次会议相关事项的独立意见 | 2021-04-27 | Chinese | ||
| 36035128 | 股东大会议事规则（2021年4月） | 2021-04-27 | Chinese | ||
| 36035120 | 对外担保管理制度（2021年4月） | 2021-04-27 | Chinese | ||
| 36035112 | 独立董事2020年度述职报告（陈菡） | 2021-04-27 | Chinese | ||
| 36035105 | 关于开展外汇套期保值业务可行性分析报告 | 2021-04-27 | Chinese | ||
| 36035101 | 关于开展商品期货套期保值业务可行性分析报告 | 2021-04-27 | Chinese | ||
| 36035094 | 关于2021年度日常关联交易预计公告 | 2021-04-27 | Chinese | ||
| 36035086 | 关于计提商誉减值准备的公告 | 2021-04-27 | Chinese | ||
| 36035081 | 关于2020年度利润分配预案的公告 | 2021-04-27 | Chinese | ||
| 36035072 | 2020年年度报告摘要 | 2021-04-27 | Chinese | ||
| 36035058 | 董事会决议公告 | 2021-04-27 | Chinese | ||
| 36035047 | 2020年度净利润实现数与净利润承诺数差异情况说明及专项审核报告 | 2021-04-27 | Chinese | ||
| 36035037 | 监事会议事规则（2021年4月） | 2021-04-27 | Chinese | ||
| 36035021 | 对外投资管理办法（2021年4月） | 2021-04-27 | Chinese | ||
| 36035014 | 公司章程修订对照表 | 2021-04-27 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ChemPartner PharmaTech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55161/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55161 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55161 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55161 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55161}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChemPartner PharmaTech Co., Ltd. (id: 55161)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.